🇺🇸 US

ONC revenue, net income and debt history (Beone Medicines Ltd.)

Quick answer

Beone Medicines Ltd. (ONC) reported revenue of $5.34B and net income of $286.9M for the fiscal year ended 2025-12-31, up 40.2% from $3.81B the year before, per its 10-K filed with the SEC on 2026-02-26. Long-term debt stood at $836.4M.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$5.34B$286.9M$836.4M
2024 (FY ending 2024-12-31)$3.81B-$644.8M$166.5M
2023 (FY ending 2023-12-31)$2.46B-$881.7M$197.6M
2022 (FY ending 2022-12-31)$1.42B-$2.00B$209.1M
2021 (FY ending 2021-12-31)$1.18B-$1.46B$202.1M
2020 (FY ending 2020-12-31)$308.9M-$1.62B$183.6M
2019 (FY ending 2019-12-31)$428.2M-$948.6M$83.3M
2018 (FY ending 2018-12-31)$198.2M-$673.8M$40.8M
2017 (FY ending 2017-12-31)$238.4M-$93.1M$9.2M
2016 (FY ending 2016-12-31)$1.1M-$119.2M$17.3M

Related

Last updated 2026-10-16. Data only, not financial or tax advice.